Device Trial Radar · NCT05339594
REINVENT Registry (Registry of the Nerve Gap Repair From Integra)
Last checked: Nov 20, 2026Latest source record: Jul 11, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
17
Actual
Start
May 30, 2022
Primary completion
Jun 3, 2024
Study completion Jun 3, 2024
Sponsor
- Lead sponsor
- Integra LifeSciences CorporationPublic (IART)
- Sponsor type
- Industry
- First posted
- Apr 21, 2022
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a prospective, multi-center, observational registry designed to evaluate two of Integra's collagen nerve gap repair products (NeuraGen® Nerve Guide and NeuraGen® 3D Nerve Guide Matrix). This registry will collect data on the outcome measures throughout the follow-up period for each patient. Data will be collected per standard of care.
Conditions
- Peripheral Nerve Injuries
Interventions
NeuraGenDevice
NeuraGen nerve guide is an absorbable implant for the repair of peripheral nerve gaps.
NeuraGen 3DDevice
NeuraGen 3D Nerve guide matrix is a resorbable implant for the repair of peripheral nerve gaps.
Primary outcomes
What the sponsor says the trial is designed to measure.
- The primary clinical outcome measure is an evaluation of meaningful recovery as expressed by the Medical Research Council (MRC) scale as determined by the 2-point discrimination test (2PD).Time frame: 18 Months
Locations
6 sites in 1 country. Site status is shown where the registry gives one.
Indiana Hand to Shoulder Center
Indianapolis, Indiana
Washington University at St Louis
St Louis, Missouri
Montefiore Medical Center
The Bronx, New York
3 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.